Subscribe to RSS
DOI: 10.1055/s-0044-1788894
The Approach to Altered Mental Status in the Intensive Care Unit
Abstract
Altered mental status (AMS) is a syndrome posing substantial burden to patients in the intensive care unit (ICU) in both prevalence and intensity. Unfortunately, ICU patients are often diagnosed merely with syndromic labels, particularly the duo of toxic–metabolic encephalopathy (TME) and delirium. Before applying a nonspecific diagnostic label, every patient with AMS should be evaluated for specific, treatable diseases affecting the central nervous system. This review offers a structured approach to increase the probability of identifying specific causal etiologies of AMS in the critically ill. We provide tips for bedside assessment in the challenging ICU environment and review the role and yield of common neurodiagnostic procedures, including specialized bedside modalities of diagnostic utility in unstable patients. We briefly review two common etiologies of TME (uremic and septic encephalopathies), and then review a selection of high-yield toxicologic, neurologic, and infectious causes of AMS in the ICU, with an emphasis on those that require deliberate consideration as they elude routine screening. The final section lays out an approach to the various etiologies of AMS in the critically ill.
Keywords
intensive care unit - encephalopathy - sepsis - altered mental status - status epilepticus - acute stroke - delirium - toxicologyPublication History
Article published online:
13 August 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Salluh JIF, Wang H, Schneider EB. et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 2015; 350: h2538
- 2 Davis DHJ, Muniz Terrera G, Keage H. et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain 2012; 135 (Pt 9): 2809-2816
- 3 Bleck TP, Smith MC, Pierre-Louis SJ, Jares JJ, Murray J, Hansen CA. Neurologic complications of critical medical illnesses. Crit Care Med 1993; 21 (01) 98-103
- 4 Schnakers C, Giacino J, Kalmar K. et al. Does the FOUR score correctly diagnose the vegetative and minimally conscious states?. Ann Neurol 2006; 60 (06) 744-745 , author reply 745
- 5 Wijdicks EFM. Clinical scales for comatose patients: the Glasgow Coma Scale in historical context and the new FOUR Score. Rev Neurol Dis 2006; 3 (03) 109-117
- 6 Ely EW, Margolin R, Francis J. et al. Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU). Crit Care Med 2001; 29 (07) 1370-1379
- 7 Frenette AJ, Bebawi ER, Deslauriers LC. et al. Validation and comparison of CAM-ICU and ICDSC in mild and moderate traumatic brain injury patients. Intensive Care Med 2016; 42 (01) 122-123
- 8 Patel MB, Bednarik J, Lee P. et al. Delirium monitoring in neurocritically ill patients: a systematic review. Crit Care Med 2018; 46 (11) 1832-1841
- 9 Davenport MS, Perazella MA, Yee J. et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 2020; 294 (03) 660-668
- 10 Young GB, Doig GS. Continuous EEG monitoring in comatose intensive care patients: epileptiform activity in etiologically distinct groups. Neurocrit Care 2005; 2 (01) 5-10
- 11 Le Guennec L, Marois C, Demeret S, Wijdicks EFM, Weiss N. Toxic-metabolic encephalopathy in adults: critical discussion and pragmatical diagnostic approach. Rev Neurol (Paris) 2022; 178 (1-2): 93-104
- 12 Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M. Neurointensive Care Section of the European Society of Intensive Care Medicine. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med 2013; 39 (08) 1337-1351
- 13 Aspide R, Bertolini G, Albini Riccioli L, Mazzatenta D, Palandri G, Biasucci DG. A proposal for a new protocol for sonographic assessment of the optic nerve sheath diameter: the CLOSED protocol. Neurocrit Care 2020; 32 (01) 327-332
- 14 Pansell J, Bell M, Rudberg P, Friman O, Cooray C. Optic nerve sheath diameter measurement by ultrasound: evaluation of a standardized protocol. J Neuroimaging 2022; 32 (01) 104-110
- 15 Cardim D, Griesdale DE, Ainslie PN. et al. A comparison of non-invasive versus invasive measures of intracranial pressure in hypoxic ischaemic brain injury after cardiac arrest. Resuscitation 2019; 137: 221-228
- 16 Olson DM, Stutzman S, Saju C, Wilson M, Zhao W, Aiyagari V. Interrater reliability of pupillary assessments. Neurocrit Care 2016; 24 (02) 251-257
- 17 Martínez-Ricarte F, Castro A, Poca MA. et al. Infrared pupillometry. Basic principles and their application in the non-invasive monitoring of neurocritical patients. Neurología 2013; 28 (01) 41-51
- 18 Oddo M, Taccone FS, Petrosino M. et al; ORANGE Study Investigators. The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study. Lancet Neurol 2023; 22 (10) 925-933
- 19 Prescott BR, Saglam H, Duskin JA. et al. Anisocoria and poor pupil reactivity by quantitative pupillometry in patients with intracranial pathology. Crit Care Med 2022; 50 (02) e143-e153
- 20 Chan WP, Prescott BR, Barra ME. et al. Dexmedetomidine and other analgosedatives alter pupil characteristics in critically ill patients. Crit Care Explor 2022; 4 (05) e0691
- 21 Ishibashi F, Kojima R, Taniguchi M, Kosaka A, Uetake H, Tavakoli M. The preferential impairment of pupil constriction stimulated by blue light in patients with type 2 diabetes without autonomic neuropathy. J Diabetes Res 2017; 2017: 6069730
- 22 Hayashi K, Yoshida M, Ishiyama S, Hirata A. Pupillary light response after cataract surgery in healthy patients. Jpn J Ophthalmol 2021; 65 (05) 616-623
- 23 Kumar VS. Parainfectious cerebral vasculopathy complicating bacterial meningitis: acute-short lived vasospasm followed by delayed-long lasting vasculitis. Brain Circ 2023; 9 (03) 135-147
- 24 Al-Mufti F, Amuluru K, Changa A. et al. Traumatic brain injury and intracranial hemorrhage-induced cerebral vasospasm: a systematic review. Neurosurg Focus 2017; 43 (05) E14
- 25 Xie A, Lo P, Yan TD, Forrest P. Neurologic complications of extracorporeal membrane oxygenation: a review. J Cardiothorac Vasc Anesth 2017; 31 (05) 1836-1846
- 26 Caturegli G, Kapoor S, Ponomarev V. et al; HERALD (Hopkins Exploration, Research, and Advancement in Life Support Devices) Investigators. Transcranial Doppler microemboli and acute brain injury in extracorporeal membrane oxygenation: a prospective observational study. JTCVS Tech 2022; 15: 111-122
- 27 Rajagopalan S, Sarwal A. Neuromonitoring in critically ill patients. Crit Care Med 2023; 51 (04) 525-542
- 28 de Riva N, Budohoski KP, Smielewski P. et al. Transcranial Doppler pulsatility index: what it is and what it isn't. Neurocrit Care 2012; 17 (01) 58-66
- 29 Rasulo FA, Calza S, Robba C. et al. Transcranial Doppler as a screening test to exclude intracranial hypertension in brain-injured patients: the IMPRESSIT-2 prospective multicenter international study. Crit Care 2022; 26 (01) 110
- 30 Cousin VL, Charbel R, Ghali N, Marais C, Tissières P. Transcranial Doppler ultrasonography in children with acute liver failure and severe hepatic encephalopathy. Pediatr Crit Care Med 2022; 23 (08) e382-e385
- 31 Monteiro LM, Bollen CW, van Huffelen AC, Ackerstaff RGA, Jansen NJG, van Vught AJ. Transcranial Doppler ultrasonography to confirm brain death: a meta-analysis. Intensive Care Med 2006; 32 (12) 1937-1944
- 32 Aliaga M, Forel JM, De Bourmont S. et al. Diagnostic yield and safety of CT scans in ICU. Intensive Care Med 2015; 41 (03) 436-443
- 33 Chokshi FH, Sadigh G, Carpenter W, Kang J, Duszak Jr R, Khosa F. Altered mental status in ICU patients: diagnostic yield of noncontrast head CT for abnormal and communicable findings. Crit Care Med 2016; 44 (12) e1180-e1185
- 34 Iglesias JE, Schleicher R, Laguna S. et al. Quantitative brain morphometry of portable low-field-strength MRI using super-resolution machine learning. Radiology 2023; 306 (03) e220522
- 35 Nothem ME, Salazar AG, Nanchal RS, Bergl PA. Diagnostic yield of combined lumbar puncture and brain MRI in critically ill patients with unexplained acute encephalopathy: a retrospective cohort study. Crit Care Explor 2023; 5 (07) e0936
- 36 Wijdicks EFM. Metabolic encephalopathy: behind the name. Neurocrit Care 2018; 29 (03) 385-387
- 37 Weiss N, Pflugrad H, Kandiah P. Altered Mental Status in the Solid Organ Transplant Recipient. . Semin Neurol 2024 (ahead of publication)
- 38 Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol 2011; 31 (02) 139-143
- 39 Arieff AI. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994; 45 (03) 629-635
- 40 Ağildere AM, Benli S, Erten Y, Coşkun M, Boyvat F, Ozdemir N. Osmotic demyelination syndrome with a dysequilibrium syndrome: reversible MRI findings. Neuroradiology 1998; 40 (04) 228-232
- 41 Stern-Nezer S. Chronic and end-stage kidney disease in the neurological intensive care unit. J Stroke Cerebrovasc Dis 2021; 30 (09) 105819
- 42 Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2001; 38 (05) 941-947
- 43 Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004; 107 (01) 1-16
- 44 Wilson JX, Young GB. Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts. Can J Neurol Sci 2003; 30 (02) 98-105
- 45 Leon A, Lepousé C, Floch T, Graftieaux JP. [Brain injury during severe sepsis]. Ann Fr Anesth Réanim 2006; 25 (08) 863-867
- 46 Robba C, Crippa IA, Taccone FS. Septic encephalopathy. Curr Neurol Neurosci Rep 2018; 18 (12) 82
- 47 Pickens CM, Hoots BE, Casillas SM, Scholl L. Prevalences of and characteristics associated with single- and polydrug-involved U.S. Emergency Department Visits in 2018. Addict Behav 2022; 125: 107158
- 48 Reisfield GM, Goldberger BA, Bertholf RL. ‘False-positive’ and ‘false-negative’ test results in clinical urine drug testing. Bioanalysis 2009; 1 (05) 937-952
- 49 Moeller KE, Kissack JC, Atayee RS, Lee KC. Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens. Mayo Clin Proc 2017; 92 (05) 774-796
- 50 Rose JJ, Wang L, Xu Q. et al. Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy. Am J Respir Crit Care Med 2017; 195 (05) 596-606
- 51 Jeon SB, Sohn CH, Seo DW. et al. Acute brain lesions on magnetic resonance imaging and delayed neurological sequelae in carbon monoxide poisoning. JAMA Neurol 2018; 75 (04) 436-443
- 52 Norkool DM, Kirkpatrick JN. Treatment of acute carbon monoxide poisoning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med 1985; 14 (12) 1168-1171
- 53 Buckley NA, Juurlink DN, Isbister G, Bennett MH, Lavonas EJ. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2011; 2011 (04) CD002041
- 54 Larson EA, Accardi MV, Zhong Y, Paquette D, Authier S. Drug-induced seizures: considerations for underlying molecular mechanisms. Int J Toxicol 2021; 40 (05) 403-412
- 55 Calic Z, Cappelen-Smith C, Zagami AS. Reversible cerebral vasoconstriction syndrome. Intern Med J 2015; 45 (06) 599-608
- 56 Gupta PK, Krishnan PR, Sudhakar PJ. Hippocampal involvement due to heroin inhalation–“chasing the dragon”. Clin Neurol Neurosurg 2009; 111 (03) 278-281
- 57 Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003; 29 (09) 1417-1425
- 58 Yahwak JA, Riker RR, Fraser GL, Subak-Sharpe S. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy 2008; 28 (08) 984-991
- 59 Aarsland D, Perry R, Larsen JP. et al. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005; 66 (05) 633-637
- 60 Ward C. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study. J Neurosci Nurs 2005; 37 (03) 160-162
- 61 Varelas PN, Corry J, Rehman M. et al. Management of status epilepticus in neurological versus medical intensive care unit: does it matter?. Neurocrit Care 2013; 19 (01) 4-9
- 62 Rossetti AO, Claassen J, Gaspard N. Status epilepticus in the ICU. Intensive Care Med 2024; 50 (01) 1-16
- 63 Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004; 62 (10) 1743-1748
- 64 Struck AF, Tabaeizadeh M, Schmitt SE. et al. Assessment of the validity of the 2HELPS2B score for inpatient seizure risk prediction. JAMA Neurol 2020; 77 (04) 500-507
- 65 Rubinos C, Reynolds AS, Claassen J. The ictal-interictal continuum: to treat or not to treat (and how)?. Neurocrit Care 2018; 29 (01) 3-8
- 66 Akbik F, Xu H, Xian Y. et al. Trends in reperfusion therapy for in-hospital ischemic stroke in the endovascular therapy era. JAMA Neurol 2020; 77 (12) 1486-1495
- 67 Sheth SA. Mechanical thrombectomy for acute ischemic stroke. Continuum (Minneap Minn) 2023; 29 (02) 443-461
- 68 Burton TM, Bushnell CD. Reversible cerebral vasoconstriction syndrome. Stroke 2019; 50 (08) 2253-2258
- 69 Hinchey J, Chaves C, Appignani B. et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334 (08) 494-500
- 70 Guzmán-De-Villoria JA, Fernández-García P, Borrego-Ruiz PJ. Neurologic emergencies in HIV-negative immunosuppressed patients. Radiología (Madr) 2017; 59 (01) 2-16
- 71 Tunkel AR, Hartman BJ, Kaplan SL. et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39 (09) 1267-1284
- 72 Leber AL, Everhart K, Balada-Llasat JM. et al. Multicenter evaluation of BioFire FilmArray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol 2016; 54 (09) 2251-2261
- 73 Van TT, Kim TH, Butler-Wu SM. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii. Clin Microbiol Infect 2020; 26 (10) 1375-1379
- 74 Wang KW, Chang WN, Huang CR. et al. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005; 12 (06) 647-650
- 75 Huhn GD, Dworkin MS. Rash as a prognostic factor in West Nile virus disease. Clin Infect Dis 2006; 43 (03) 388-389
- 76 Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353 (05) 451-459
- 77 Sejvar JJ, Haddad MB, Tierney BC. et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290 (04) 511-515
- 78 Cunha BA, Sachdev B, Canario D. Serum ferritin levels in West Nile encephalitis. Clin Microbiol Infect 2004; 10 (02) 184-186
- 79 Halperin JJ. Diagnosis and management of acute encephalitis. In: Handbook of Clinical Neurology. Vol 140. Elsevier; 2017: 337-347
- 80 Shimoni Z, Bin H, Bulvik S. et al. The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy. Clin Pract 2012; 2 (01) e18
- 81 Cunha CB, Cunha BA. Legionnaire's disease since Philadelphia: lessons learned and continued progress. Infect Dis Clin North Am 2017; 31 (01) 1-5
- 82 Cunha BA, Wu G, Raza M. Clinical diagnosis of Legionnaire's disease: six characteristic clinical predictors. Am J Med 2015; 128 (07) e21-e22
- 83 Gacouin A, Revest M, Letheulle J. et al. Distinctive features between community-acquired pneumonia (CAP) due to Chlamydophila psittaci and CAP due to Legionella pneumophila admitted to the intensive care unit (ICU). Eur J Clin Microbiol Infect Dis 2012; 31 (10) 2713-2718
- 84 Cunha BA, Cunha CB. Legionnaire's disease. Infect Dis Clin North Am 2017; 31 (01) 81-93
- 85 Daxboeck F. Mycoplasma pneumoniae central nervous system infections. Curr Opin Neurol 2006; 19 (04) 374-378
- 86 Jeanneret V, Beach PA, Kase CS. Ocular dipping in anoxic brain injury. JAMA Neurol 2019; 76 (10) 1252
- 87 Judge BS. Metabolic acidosis. Emerg Med Clin North Am 2022; 40 (02) 251-264
- 88 Kreisberg RA, Wood BC. Drug and chemical-induced metabolic acidosis. Clin Endocrinol Metab 1983; 12 (02) 391-411
- 89 Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord 2014; 24 (08) 651-659
- 90 Cai A, Cai X. Toxin-induced acute delirium. Neurol Clin 2020; 38 (04) 781-798
- 91 Azevedo K, Johnson M, Wassermann M, Evans-Wall J. Drugs of abuse-opioids, sedatives, hypnotics. Crit Care Clin 2021; 37 (03) 501-516
- 92 Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352 (11) 1112-1120
- 93 Kale N. Urine drug tests: ordering and interpreting results. Am Fam Physician 2019; 99 (01) 33-39
- 94 Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol 2014; 38 (07) 387-396
- 95 Wanleenuwat P, Suntharampillai N, Iwanowski P. Antibiotic-induced epileptic seizures: mechanisms of action and clinical considerations. Seizure 2020; 81: 167-174
- 96 Sutter R, Rüegg S, Tschudin-Sutter S. Seizures as adverse events of antibiotic drugs: a systematic review. Neurology 2015; 85 (15) 1332-1341
- 97 Cunha CB, Cunha BA. Infectious Diseases and Antimicrobial Stewardship in Critical Care Medicine. CRC PRESS; 2022